1.
Transplantation
; 105(8): e84-e86, 2021 08 01.
Article
in English
| MEDLINE | ID: covidwho-1266244
Subject(s)
COVID-19 Vaccines/adverse effects , COVID-19/prevention & control , Organ Transplantation , Purpura, Thrombotic Thrombocytopenic/etiology , SARS-CoV-2/immunology , Tissue Donors , Aged , COVID-19/immunology , COVID-19/virology , COVID-19 Vaccines/administration & dosage , ChAdOx1 nCoV-19 , Donor Selection , Fatal Outcome , Female , Humans , Male , Middle Aged , Organ Transplantation/adverse effects , Risk Assessment , Risk Factors , Treatment Outcome , Vaccination/adverse effects
2.
J Gynecol Obstet Hum Reprod
; 50(3): 102064, 2021 Mar.
Article
in English
| MEDLINE | ID: covidwho-1030911
ABSTRACT
BACKGROUND: Data about obstetric complications of maternal infection by SARS-CoV-2 remain sparse. CASE: A 40-year-old pregnant woman, gravida 3 para 1 with no previous obstetric complications, presented a late miscarriage at 16 weeks of gestation on day 9 of COVID-19 disease. The results of her nasopharyngeal swab for SARS-CoV-2, tested the same day, were negative, but the placenta was infected by SARS-CoV-2 and serology was positive 11 days later. No other obstetric or infectious cause was found to explain this outcome. CONCLUSION: This case strongly suggests that SARS-CoV-2 may lead to a late miscarriage.